Literature DB >> 18246737

Nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae in healthy children.

Arzu Uzuner1, Arzu Ilki, Mehmet Akman, Ercan Gündoğdu, Riza Erbölükbaş, Omer Kokaçya, Türkan Mengüç, Sibel Kalaça, Güner Söyletir.   

Abstract

Streptococcus pneumoniae carriage is a risk factor for the development of respiratory system infections and the spread of penicillin-resistant strains. The aim of this study was to investigate nasopharyngeal carriage of S. pneumoniae in healthy children and resistance to penicillin and other antimicrobials and to assess related risk factors. Nasopharyngeal specimens collected from healthy children less than six years of age, visiting a Mother and Child Health Center for health control, were investigated microbiologically between February-March 2004. Carriage rate was 37.2% (n=112/301); 33.9% intermediate and 5.4% high penicillin resistance were detected. According to multivariate analysis, carriage rate was inversely related to number of rooms (OR:0.574) and child age (OR:0.978), while penicillin resistance was correlated well with antibiotic use in the last two months (OR:2.193). Decreased sensitivity plus resistance to other antimicrobials were: trimethoprim-sulfamethoxazole (TMP-SMX) 45.6%; erythromycin 16.1%, tetracycline 16.1%; clindamycin 9.8%, and ofloxacin 3.6% in pneumococcal isolates, which increased significantly (p<0.05) to 72.7%, 31.8%, 27.3%, 20.5%, and 6.8%, respectively, in penicillin non-sensitive S. pneumoniae (PNSSP) except for ofloxacin. Overall multidrug resistance was 17.9%, while PNSSP exhibited a resistance rate of 38.6%. In conclusion, S. pneumoniae carriage rates determined in healthy children were high and PNSSP strains also showed increased resistance to other antimicrobials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18246737

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  6 in total

1.  Rapid detection of Streptococcus pneumoniae by real-time fluorescence loop-mediated isothermal amplification.

Authors:  Yong Xia; Xu-Guang Guo; Shan Zhou
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

2.  Nasopharyngeal carriage of Streptococcus pneumoniae in healthy Turkish children after the addition of PCV7 to the national vaccine schedule.

Authors:  Halil Ozdemir; Ergin Ciftçi; Rıza Durmaz; Haluk Güriz; Ahmet Derya Aysev; Adem Karbuz; Refik Gökdemir; Bülent Acar; Selin Nar Ötgün; Mustafa Ertek; Serdal Kenan Köse; Erdal Ince
Journal:  Eur J Pediatr       Date:  2013-09-18       Impact factor: 3.183

3.  A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).

Authors:  Fyezah Jehan; Muhammad Imran Nisar; Salima Kerai; Nick Brown; Benazir Balouch; Zulfiqar Hyder; Gwen Ambler; Amy Sarah Ginsburg; Anita K M Zaidi
Journal:  BMC Infect Dis       Date:  2016-01-13       Impact factor: 3.090

Review 4.  Should fast breathing pneumonia cases be treated with antibiotics? The scientific rationale for revisiting management in Low and Middle income countries.

Authors:  Fyezah Jehan; Imran Nisar; Salima Kerai; Nick Brown; Gwen Ambler; Anita K M Zaidi
Journal:  Int J Infect Dis       Date:  2019-06-05       Impact factor: 3.623

Review 5.  Risk factors for carriage of antimicrobial-resistant bacteria in community dwelling-children in the Asia-Pacific region: a systematic review and meta-analysis.

Authors:  Yi Qi Chan; Kailin Chen; Gilbert T Chua; Peng Wu; Keith T S Tung; Hing Wai Tsang; David Lung; Patrick Ip; Celine S L Chui
Journal:  JAC Antimicrob Resist       Date:  2022-04-19

6.  High prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda: A cross-sectional study.

Authors:  Elizeus Rutebemberwa; Betty Mpeka; George Pariyo; Stefan Peterson; Edison Mworozi; Freddie Bwanga; Karin Källander
Journal:  Ups J Med Sci       Date:  2015-08-25       Impact factor: 2.384

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.